United States (US) Peripheral Artery Disease Market (2025-2031) | Industry, Outlook, Forecast, Growth, Companies, Competitive Landscape, Analysis, Size & Revenue, Trends, Share, Value, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Peripheral Artery Disease Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Peripheral Artery Disease Market - Industry Life Cycle

3.4 United States (US) Peripheral Artery Disease Market - Porter's Five Forces

3.5 United States (US) Peripheral Artery Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United States (US) Peripheral Artery Disease Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of lifestyle-related diseases such as diabetes and obesity leading to a higher incidence of peripheral artery disease in the US.

4.2.2 Growing aging population, as the risk of developing peripheral artery disease increases with age.

4.2.3 Technological advancements in minimally invasive procedures and devices for the treatment of peripheral artery disease.

4.3 Market Restraints

4.3.1 High cost associated with the diagnosis and treatment of peripheral artery disease, limiting access to care for some patients.

4.3.2 Lack of awareness among the general population about peripheral artery disease, leading to underdiagnosis and undertreatment.

4.3.3 Regulatory challenges and reimbursement issues impacting the adoption of new technologies and treatments for peripheral artery disease.

6.1 United States (US) Peripheral Artery Disease Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Peripheral Artery Disease Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United States (US) Peripheral Artery Disease Market Revenues & Volume, By Devices, 2021- 2031F

6.1.4 United States (US) Peripheral Artery Disease Market Revenues & Volume, By Drugs, 2021- 2031F

6.2 United States (US) Peripheral Artery Disease Market, By End User

6.2.1 Overview and Analysis

6.2.2 United States (US) Peripheral Artery Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.2.3 United States (US) Peripheral Artery Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

7.1 United States (US) Peripheral Artery Disease Market Export to Major Countries

7.2 United States (US) Peripheral Artery Disease Market Imports from Major Countries

8.1 Average waiting time for peripheral artery disease diagnosis and treatment.

8.2 Number of peripheral artery disease screenings conducted annually.

8.3 Patient satisfaction rates with peripheral artery disease treatment and care.

8.4 Rate of adoption of minimally invasive procedures for peripheral artery disease treatment.

8.5 Number of healthcare providers specializing in peripheral artery disease management.

9.1 United States (US) Peripheral Artery Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United States (US) Peripheral Artery Disease Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 United States (US) Peripheral Artery Disease Market Revenue Share, By Companies, 2024

10.2 United States (US) Peripheral Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters